Patients with secondary causes of osteoporosis (e.g., hyperparathyroidism, Cushing's syndrome).

Use of medications affecting bone metabolism (e.g., glucocorticoids \>7.5 mg/day, bisphosphonates, denosumab) within the past year.

History of metabolic bone diseases other than osteoporosis (e.g., osteomalacia, Paget's disease).

Patients with a history of malignancy, except for non-melanoma skin cancer.

Incomplete or missing data required for FRAX or DXA analysis.

Any condition or comorbidity likely to affect fracture risk assessment, as determined by the clinician.

Impact of Bone Mineral Density on Fracture Risk Assessment in RA